Burning Rock Biotech Ltd Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -62.41M-124.74M-140.24M-91.40M-45.88M
Depreciation and Depletion 4.97M7.00M17.51M18.52M7.04M
Share-based Compensation 26.55M44.32M47.38M36.72M21.32M
Gains from Investment Securities 0.75M0.17M-0.21M-0.14M-0.30M
Asset Writedowns and Impairment 2.09M4.81M
Cash from Operations -11.27M-74.99M-66.23M-36.03M-12.64M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 5.11M7.50M17.99M18.79M7.15M
Change in Working Capital
Change in Receivables 2.00M2.97M3.12M1.75M4.47M
Change in Inventory 1.45M10.51M3.14M-8.07M-0.34M
Change in Account Payables 3.96M-0.80M2.41M-4.38M2.59M
Change in Accured Expenses 4.54M6.94M4.88M-2.71M-1.19M
Other Working Capital Changes 3.81M10.74M-5.48M-5.32M-3.78M
Investing Activities
Capital Expenditures 9.24M32.06M8.99M1.14M0.74M
Sales of Property, Plant and Equipment 0.10M0.09M0.35M0.01M0.21M
Change in Intangibles 0.61M0.40M0.03M0.18M0.08M
Change in Acquisitions & Divestments 48.74M56.26M9.51M
Cash from Investing Activities -16.75M12.82M-1.08M-1.31M-0.60M
Financing Activities
Cash from Financing Activities 331.91M-8.30M-12.50M-6.88M-0.01M
Additional items
Exchange Rate Effect -23.89M-5.81M5.32M0.54M0.51M
Change in Cash 279.99M-76.28M-74.50M-43.67M-12.75M
Beginning Cash Balance 10.47M300.88M205.78M130.30M83.97M
Free Cash Flow -20.51M-107.05M-75.23M-37.17M-13.38M
Net Cash Flow 303.89M-70.47M-79.82M-44.21M-13.25M